Literature DB >> 10713454

Major transcript variants of VAV3, a new member of the VAV family of guanine nucleotide exchange factors.

T Trenkle1, M McClelland, K Adlkofer, J Welsh.   

Abstract

VAV3 is a new member of the VAV oncogene family with a strong homology to VAV and VAV2. A conceptual translation of the cDNA indicates that VAV3 is between 40 and 77% identical to VAV and VAV2 at the amino acid level in all identified functional motifs. This homology suggests that VAV3 occupies a similar position in signal transduction as the other family members. A major variant transcript, VAV3.1, found in both humans and mice, appears to encode only the 3' SH3-SH2-SH3 region, which suggests that it may substitute for the full-length isoform in functions mediated by this domain, or compete with the full-length isoform in functions mediated by more N-terminal motifs. VAV3.1 either is a partly unspliced mRNA or originates from a different promoter. VAV3 transcripts are found in cells of hematopoietic origin, where VAV is primarily expressed. However, unlike, VAV, the VAV3 and VAV3.1 transcripts are also found at varying levels in a wide variety of other tissues and cell lines. TGF-beta and EGF reversibly down-regulate the abundance of the VAV3. 1 transcript in HaCaT keratinocytes, representing the first observation of transcript regulation of a member of the VAV family by a growth factor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10713454     DOI: 10.1016/s0378-1119(00)00026-3

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  15 in total

1.  Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation.

Authors:  L Zeng; P Sachdev; L Yan; J L Chan; T Trenkle; M McClelland; J Welsh; L H Wang
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  Nonobese diabetic congenic strain analysis of autoimmune diabetes reveals genetic complexity of the Idd18 locus and identifies Vav3 as a candidate gene.

Authors:  Heather I Fraser; Calliope A Dendrou; Barry Healy; Daniel B Rainbow; Sarah Howlett; Luc J Smink; Simon Gregory; Charles A Steward; John A Todd; Laurence B Peterson; Linda S Wicker
Journal:  J Immunol       Date:  2010-04-02       Impact factor: 5.422

3.  Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesis.

Authors:  Sonja G Hunter; Guanglei Zhuang; Dana Brantley-Sieders; Wojciech Swat; Christopher W Cowan; Jin Chen
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

Review 4.  Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation.

Authors:  Heather E Wheeler; M Eileen Dolan
Journal:  Pharmacogenomics       Date:  2012-01       Impact factor: 2.533

5.  Bypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models.

Authors:  Rute B Marques; Natasja F Dits; Sigrun Erkens-Schulze; Wytske M van Weerden; Guido Jenster
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

Review 6.  Rho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and disease.

Authors:  D R Cook; K L Rossman; C J Der
Journal:  Oncogene       Date:  2013-09-16       Impact factor: 9.867

7.  A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancer.

Authors:  S Rao; L S Lyons; C D Fahrenholtz; F Wu; A Farooq; W Balkan; K L Burnstein
Journal:  Oncogene       Date:  2011-07-18       Impact factor: 9.867

8.  An effector region in Eps8 is responsible for the activation of the Rac-specific GEF activity of Sos-1 and for the proper localization of the Rac-based actin-polymerizing machine.

Authors:  G Scita; P Tenca; L B Areces; A Tocchetti; E Frittoli; G Giardina; I Ponzanelli; P Sini; M Innocenti; P P Di Fiore
Journal:  J Cell Biol       Date:  2001-08-27       Impact factor: 10.539

9.  Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers.

Authors:  Liang Li; Brooke L Fridley; Krishna Kalari; Gregory Jenkins; Anthony Batzler; Richard M Weinshilboum; Liewei Wang
Journal:  PLoS One       Date:  2009-11-09       Impact factor: 3.240

10.  Vav2 is required for cell spreading.

Authors:  P A Marignani; C L Carpenter
Journal:  J Cell Biol       Date:  2001-07-09       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.